Results 131 to 140 of about 24,724 (196)

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML. [PDF]

Hemasphere
Fiskus W, Mill CP, Piel J, Collins M, Hentemann M, Cuglievan B, Birdwell CE, Das K, Davis JA, Hou H, Jain A, Malovannaya A, Flores LB, Kadia TM, Daver N, Sasaki K, Takahashi K, Hammond D, Wang J, Loghavi S, Su X, DiNardo CD, Delwel R, Bhalla KN.   +23 more
europepmc   +1 more source

SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer. [PDF]

Sci Rep
Guo Y, Zhou X, Xu H, Wang G.
europepmc   +1 more source

Integrating Targeted Therapies into AML Frontline Therapy: Who Gets What and What Does the Future Hold? [PDF]

Cancers (Basel)
Schreiber J, Hopfinger G, Gleixner KV.
europepmc   +1 more source

Second allogeneic stem cell transplantation for XMEN disease. [PDF]

BMJ Case Rep
Wirk B.
europepmc   +1 more source

Decitabine-mediated DNA methylation dynamics at pericentromeric satellite 2 repeats. [PDF]

BMC Cancer
Sordini E, Ciurlia E, Zanella A, Fogliardi B, Lame D, Poloni A, Amatori S, Fanelli M.   +7 more
europepmc   +1 more source

Regulation of major histocompatibility complex class-I (MHC-I) gene methylation using DNA methyltransferase inhibitor and PD-L1 inhibitor in triple negative breast cancer. [PDF]

Discov Oncol
Jeong YJ, Lee NR, Oh HK.
europepmc   +1 more source

The molecular mechanisms and potential therapeutic implications of the crosstalk between DNA methylation and metabolic reprogramming in thyroid cancer. [PDF]

Cell Death Discov
Zhang T, Han H, Zhang Y, Zhang T, Ma L, Yang Z, Zhao YX.   +6 more
europepmc   +1 more source

Current and emerging maintenance strategies after stem cell transplantation in children and adolescents with acute leukemias. [PDF]

Mol Ther Oncol
Rankin AW, Keating AK, Abu-Arja RF, Thakar MS, Rangarajan HG.   +4 more
europepmc   +1 more source

Low-dose Decitabine Vs best supportive care in older patients with AML and low blast counts: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC leukemia cooperative group and german MDS study group [PDF]

, 2013
AUL, Carlo, BARON, Frédéric, BECKER, Heiko, DE WITTE, Theo, GANSER, Arnold, GERMING, Ulrich, GIAGOUNIDIS, Aristoteles, HAGEMEIJER, Anne, LABAR, Boris, LUBBERT, Michael, MUUS, Petra, PFLUGER, Karl-Heinz, PLATZBECKER, Uwe, RUTER, Björn, SALIH, Helmut R., SCHAEFER, Hans-Eckart, SELLESLAG, Dominik, SUCIU, Stefan, WIJERMANS, Pierre W.   +18 more
core  

Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy. [PDF]

Cancers (Basel)
Riyas Mohamed FR, Aldubaisi S, Akbar A, Khan MI, Yaqinuddin A.   +4 more
europepmc   +1 more source